Cargando…
Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
Expression of the bcl-2 gene was investigated in 218 human breast carcinomas by immunohistochemical analysis. Immunodetections were assessed using (1) frozen sections, (2) documented commercially available monoclonal antibody (bcl-2/124, Dako), (3) automation of immunoperoxidase technique (Ventana)...
Autores principales: | Charpin, C., Garcia, S., Bouvier, C., Devictor, B., Andrac, L., Lavaut, M. N., Allasia, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2224069/ https://www.ncbi.nlm.nih.gov/pubmed/9252201 |
Ejemplares similares
-
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
por: Charpin, C., et al.
Publicado: (1997) -
VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
por: Charpin, C., et al.
Publicado: (1998) -
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
por: Charpin, C, et al.
Publicado: (2009) -
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007) -
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004)